Cheapest Mounjaro and Metformin - UK Price £124.99

Our Pricing

Mounjaro & Metformin Bundle Savings - From £124.99

Published on: June 03, 2026

Many UK patients ask whether they can take mounjaro and metformin together uk for enhanced weight loss and blood sugar control. At Cured Pharmacy, our UK-registered clinical team assesses combination therapy on an individual basis, with Mounjaro available from £124.99 following your free online consultation. This comprehensive guide explains how these medications work together, who may benefit, and what the clinical evidence shows.

Can You Take Mounjaro and Metformin Together?

Yes, Mounjaro (tirzepatide) and metformin can be prescribed together in the UK, and this combination is commonly used in clinical practice [1]. Both medications are licensed by the MHRA for different indications — tirzepatide as a dual GIP/GLP-1 receptor agonist for weight management and type 2 diabetes, and metformin as a first-line oral medication that reduces glucose production in the liver.

The combination works through complementary mechanisms: metformin primarily reduces hepatic glucose output and improves insulin sensitivity, whilst Mounjaro activates two incretin pathways to slow gastric emptying, reduce appetite, and enhance insulin secretion [1][2]. Clinical trials have demonstrated that patients already taking metformin who add tirzepatide achieve significantly greater weight loss and HbA1c reductions compared to metformin alone.

Your UK prescriber will assess whether combination therapy is appropriate based on your medical history, current medications, kidney function, and treatment goals. Not everyone requires both medications — some patients achieve excellent results with Mounjaro alone, whilst others benefit from the metabolic support that metformin provides alongside injectable therapy.

Clinical Evidence for Mounjaro and Metformin Combination

The SURPASS clinical trial programme included thousands of patients taking metformin as background therapy whilst initiating tirzepatide [1]. In SURPASS-2, participants on metformin who added tirzepatide 15mg achieved an average 12.4kg weight loss over 40 weeks, compared to 2.8kg with continued metformin alone — a statistically significant difference that demonstrates the added benefit of combination therapy.

HbA1c reductions were equally impressive: patients on the tirzepatide-metformin combination saw average reductions of 2.3% from baseline, with 93% of participants achieving target HbA1c levels below 7% [1][3]. These results suggest that for patients with type 2 diabetes or prediabetes, combining these medications may optimise both weight and glycaemic outcomes.

Importantly, the safety profile remained consistent across monotherapy and combination groups. Gastrointestinal side effects — primarily nausea, diarrhoea, and reduced appetite — were the most commonly reported adverse events, occurring in approximately 20-30% of participants but typically diminishing after the first few weeks of treatment [1][4].

Real-World UK Clinical Experience

In our experience at Cured Pharmacy, patients already established on metformin who add Mounjaro often report enhanced satiety and more consistent energy levels throughout the day. Superintendent Pharmacist Tarun Kumar notes that the combination appears particularly beneficial for patients who have plateaued on metformin alone or who require additional support for weight management alongside blood sugar control. Every patient responds differently, and our UK prescribers tailor treatment plans based on individual clinical presentation and response to therapy.

Who Benefits Most from Mounjaro and Metformin Together UK?

Combination therapy may be particularly suitable for UK patients with type 2 diabetes who have not achieved adequate glycaemic control with metformin alone, or for those with obesity and insulin resistance who require multi-pathway metabolic support [2][3]. NICE guidelines support the use of GLP-1 receptor agonists as add-on therapy when first-line oral medications prove insufficient.

Patients with a BMI over 30 (or over 27 with weight-related comorbidities) who also have elevated HbA1c levels often derive the greatest benefit from this combination. The complementary mechanisms address both the weight management and metabolic dysfunction aspects of their condition, potentially reducing cardiovascular risk factors more effectively than either medication alone [4].

However, combination therapy is not suitable for everyone. Patients with a history of pancreatitis, severe gastrointestinal disease, type 1 diabetes, or significant kidney impairment may not be appropriate candidates. Your UK prescriber will review your full medical history, current medications, and recent blood test results before determining whether Mounjaro and metformin together is the right approach for you.

When Mounjaro Alone May Be Sufficient

Some patients achieve excellent weight loss and metabolic improvements with Mounjaro monotherapy, particularly those without established diabetes or those who have experienced side effects with metformin in the past. Tirzepatide's dual incretin action produces robust effects on appetite, glucose metabolism, and body weight without requiring additional oral medication. Your prescriber will discuss whether starting with Mounjaro alone or combining it with existing metformin therapy best suits your clinical needs.

Mounjaro and Metformin Together UK: Dosing and Administration

Mounjaro is administered as a once-weekly subcutaneous injection using a pre-filled KwikPen device, starting at 2.5mg for the first four weeks before gradually increasing to therapeutic doses of 5mg, 7.5mg, 10mg, 12.5mg, or 15mg based on individual response and tolerability [1]. This dose escalation approach minimises gastrointestinal side effects whilst allowing your body to adjust to the medication's effects.

Metformin is typically prescribed as 500mg to 1000mg taken once or twice daily with meals, though your existing dose will remain unchanged when adding Mounjaro unless your prescriber advises otherwise. The timing of metformin doses does not need to be coordinated with your weekly Mounjaro injection — you simply continue your established metformin routine whilst adding the once-weekly injection on the same day each week.

Patients should be aware that the combination may increase the likelihood of gastrointestinal side effects during the first few weeks of treatment. Starting with the lowest Mounjaro dose and maintaining adequate hydration can help minimise these effects. If you experience persistent nausea, vomiting, or diarrhoea, contact your prescriber — dose adjustments or temporary medication changes may be necessary.

Mounjaro Metformin Bundle UK: What to Expect

At Cured Pharmacy, patients prescribed both medications receive them together with comprehensive guidance on administration, storage, and what to expect during treatment. Your bundle includes genuine UK-licensed Mounjaro KwikPens dispensed in discreet packaging, with metformin supplied separately if prescribed by your UK clinician following your free online consultation.

The consultation process takes under three minutes and covers your medical history, current medications, weight management goals, and any previous experience with diabetes or weight loss treatments. Our UK-registered prescribers review your assessment the same day, and if approved, your medications are dispatched from our GPhC-registered pharmacy with next-day delivery options available across the UK.

Pricing remains transparent from the start: Mounjaro costs from £124.99 depending on your prescribed dose, with all costs shown before you complete your consultation. There are no hidden fees, subscription traps, or surprise charges — you see exactly what you'll pay upfront, and you can cancel or adjust your treatment plan at any time by contacting our clinical team.

Ongoing Clinical Support

Every patient prescribed Mounjaro and metformin through Cured Pharmacy receives access to our UK clinical team for questions, dose adjustments, or side effect management. We recommend follow-up assessments every 12 weeks to monitor your progress, review any side effects, and ensure the combination continues to meet your treatment goals. Your prescriber may adjust doses, recommend blood tests, or modify your treatment plan based on your individual response and any changes in your health status.

Alternative Weight Loss Treatments Available at Cured Pharmacy

Whilst Mounjaro and metformin combination therapy offers powerful metabolic benefits, it is not the only evidence-based weight loss option available through our UK pharmacy. Patients who do not require metformin, prefer oral medications, or have contraindications to injectable therapy may consider alternative treatments tailored to their clinical profile.

Wegovy (semaglutide) is another once-weekly injectable GLP-1 receptor agonist licensed in the UK for weight management, producing average weight loss of 15% over 68 weeks in the STEP clinical trials [5]. Unlike Mounjaro's dual incretin action, Wegovy works through a single GLP-1 pathway but remains highly effective for appetite suppression and sustainable weight reduction. Some patients find semaglutide better tolerated than tirzepatide, whilst others achieve superior results with Mounjaro's dual mechanism.

For patients preferring oral medication, Wegovy Oral Tablets provide the same active ingredient as the injection in convenient pill form, whilst Orlistat and Xenical work through fat absorption inhibition rather than appetite regulation. Your UK prescriber will discuss which treatment aligns best with your medical history, lifestyle preferences, and weight loss goals during your free consultation.

Comparing Injectable and Oral Options

Injectable treatments like Mounjaro and Wegovy generally produce greater weight loss than oral alternatives, but require weekly self-administration using pre-filled pens. Oral medications offer convenience without injections but may produce more modest results. Your choice depends on your comfort level with injections, the degree of weight loss you are targeting, and any medical factors that favour one approach over another. Our clinical team helps you weigh these considerations to select the most appropriate treatment for your individual circumstances.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
2. Frías, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519 [accessed 13 August 2026]
3. Ludvik, B., Giorgino, F., Jódar, E., et al. (2021). Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial. The Lancet, 398(10300), 583–598. https://doi.org/10.1016/S0140-6736(21)01443-4 [accessed 13 August 2026]
4. Dahl, D., Onishi, Y., Norwood, P., et al. (2022). Effect of Subcutaneous Tirzepatide vs Placebo Added to Titrated Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes: The SURPASS-5 Randomized Clinical Trial. JAMA, 327(6), 534–545. https://doi.org/10.1001/jama.2022.0078 [accessed 13 August 2026]
5. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
6. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
7. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
8. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and the information provided does not guarantee specific outcomes. Mounjaro and metformin are prescription-only medicines in the UK, licensed by the MHRA for specific indications as determined by your prescriber.